• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌瘤内情况:解析与激素受体的相互作用及对肿瘤免疫的影响

Intratumoral in Breast Cancer: Unraveling the Interplay with Hormone Receptors and Impact on Tumor Immunity.

作者信息

Zhang Qian, Wang Dujuan, Zhuo Guangzheng, Wang Shilin, Yuan Yufen, Wang Liping, Ji Lili, Wan Yuhang, Liu Guohong, Pan Yunbao

机构信息

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

Department of Clinical Pathology, Houjie Hospital of Dongguan, The Affiliated Houjie Hospital of Guangdong Medical University, Dongguan, China.

出版信息

Int J Biol Sci. 2025 Jan 6;21(3):974-988. doi: 10.7150/ijbs.98260. eCollection 2025.

DOI:10.7150/ijbs.98260
PMID:39897027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11781185/
Abstract

This study aimed to explore the impact of intratumoral microorganisms in conjunction with hormone receptors on the tumor microenvironment and their potential role in predicting patient prognosis. Significant bacterial variations were identified within ER, PR, HER2, and triple-negative breast cancer subtypes. Kaplan-Meier survival analysis was employed to identify bacteria associated with patient survival. Further, a humanized immune system mouse model bearing breast cancer xenografts was used to evaluate the effects of () on tumor growth and CD8+ T cell infiltration. Additional validation experiments included fluorescence in situ hybridization for , CD8+ T cell chemotaxis, and intracellular cytokine detection. , , and were identified as significant prognostic species. Notably, tumor-infiltrating immune cells, particularly CD8+ T cells, exhibited a positive association with the presence of . Experimental validation with clinically isolated further confirmed its positive correlation with CD8+ T cell activation. findings demonstrated that inhibited tumor growth and promoted CD8+ T cell infiltration, highlighting the complex interactions between intratumoral microbiota and tumor immunity in breast cancer. These insights contribute to the understanding of microbial influences on the tumor microenvironment and suggest potential pathways for improving patient prognosis through microbiota modulation.

摘要

本研究旨在探讨肿瘤内微生物与激素受体共同作用对肿瘤微环境的影响及其在预测患者预后方面的潜在作用。在雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)和三阴性乳腺癌亚型中发现了显著的细菌差异。采用Kaplan-Meier生存分析来确定与患者生存相关的细菌。此外,利用携带乳腺癌异种移植瘤的人源化免疫系统小鼠模型来评估()对肿瘤生长和CD8+ T细胞浸润的影响。额外的验证实验包括针对()的荧光原位杂交、CD8+ T细胞趋化性和细胞内细胞因子检测。()、()和()被确定为显著的预后菌种。值得注意的是,肿瘤浸润免疫细胞,尤其是CD8+ T细胞,与()的存在呈正相关。对临床分离的()进行实验验证进一步证实了其与CD8+ T细胞活化的正相关性。()研究结果表明,()抑制肿瘤生长并促进CD8+ T细胞浸润,突出了乳腺癌肿瘤内微生物群与肿瘤免疫之间的复杂相互作用。这些见解有助于理解微生物对肿瘤微环境的影响,并提示通过调节微生物群改善患者预后的潜在途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/b9b8edf8ec12/ijbsv21p0974g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/2b05c9f5abeb/ijbsv21p0974g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/518b14a3d373/ijbsv21p0974g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/b329f24ae660/ijbsv21p0974g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/d51cbee56fb2/ijbsv21p0974g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/9abebad1335b/ijbsv21p0974g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/a57620a16f04/ijbsv21p0974g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/688f6e576eec/ijbsv21p0974g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/b9b8edf8ec12/ijbsv21p0974g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/2b05c9f5abeb/ijbsv21p0974g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/518b14a3d373/ijbsv21p0974g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/b329f24ae660/ijbsv21p0974g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/d51cbee56fb2/ijbsv21p0974g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/9abebad1335b/ijbsv21p0974g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/a57620a16f04/ijbsv21p0974g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/688f6e576eec/ijbsv21p0974g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c8/11781185/b9b8edf8ec12/ijbsv21p0974g008.jpg

相似文献

1
Intratumoral in Breast Cancer: Unraveling the Interplay with Hormone Receptors and Impact on Tumor Immunity.乳腺癌瘤内情况:解析与激素受体的相互作用及对肿瘤免疫的影响
Int J Biol Sci. 2025 Jan 6;21(3):974-988. doi: 10.7150/ijbs.98260. eCollection 2025.
2
Spatial distributions of CD8 and Ki67 cells in the tumor microenvironment independently predict breast cancer-specific survival in patients with ER+HER2- and triple-negative breast carcinoma.肿瘤微环境中 CD8 和 Ki67 细胞的空间分布独立预测 ER+/HER2- 和三阴性乳腺癌患者的乳腺癌特异性生存。
PLoS One. 2024 Nov 22;19(11):e0314364. doi: 10.1371/journal.pone.0314364. eCollection 2024.
3
Progesterone receptor impairs immune respond and down-regulates sensitivity to anti-LAG3 in breast cancer.孕激素受体损害免疫应答,并降低乳腺癌患者对抗 LAG3 的敏感性。
Transl Res. 2024 Sep;271:68-78. doi: 10.1016/j.trsl.2024.05.001. Epub 2024 May 24.
4
Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer.乳腺癌中PBK/TOPK表达、预后及免疫浸润的相关性研究
Sci Rep. 2025 Apr 29;15(1):15052. doi: 10.1038/s41598-025-96542-1.
5
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.CD8+ 淋巴细胞浸润是基底样乳腺癌的一个独立预后良好的指标。
Breast Cancer Res. 2012 Mar 15;14(2):R48. doi: 10.1186/bcr3148.
6
Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.FOXP3+肿瘤浸润淋巴细胞在乳腺癌中的预后意义取决于雌激素受体和人表皮生长因子受体2的表达状态以及同时存在的细胞毒性T细胞浸润情况。
Breast Cancer Res. 2014 Sep 6;16(5):432. doi: 10.1186/s13058-014-0432-8.
7
COPS6 promotes tumor progression and reduces CD8 T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast cancer.COPS6 通过抑制 IL-6 的产生促进肿瘤进展并减少 CD8 T 细胞浸润,从而促进乳腺癌的肿瘤免疫逃逸。
Acta Pharmacol Sin. 2023 Sep;44(9):1890-1905. doi: 10.1038/s41401-023-01085-8. Epub 2023 Apr 24.
8
Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer.维生素 D 可控制乳腺癌肿瘤生长和 CD8+T 细胞浸润。
Front Immunol. 2019 Jun 6;10:1307. doi: 10.3389/fimmu.2019.01307. eCollection 2019.
9
Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.初次复发时转移性三阴性乳腺癌的肿瘤浸润淋巴细胞比其匹配的原发性乳腺癌肿瘤更少:一项初步研究。
Hum Pathol. 2013 Oct;44(10):2055-63. doi: 10.1016/j.humpath.2013.03.010. Epub 2013 May 21.
10
Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.利用 PET 成像评估乳腺癌小鼠模型中免疫检查点抑制剂治疗后 CD4+和 CD8+T 细胞的免疫“冷”肿瘤微环境。
Breast Cancer Res. 2024 Jun 25;26(1):104. doi: 10.1186/s13058-024-01844-3.

本文引用的文献

1
Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma.核梭杆菌感染细胞可减弱食管鳞状细胞癌中的抗肿瘤免疫。
Nat Commun. 2023 Sep 18;14(1):5788. doi: 10.1038/s41467-023-40987-3.
2
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment.鉴定空间异质性乳腺癌微环境中的预后标志物。
J Transl Med. 2023 Aug 29;21(1):580. doi: 10.1186/s12967-023-04395-x.
3
Infection caused by Lawsonella clevelandensis after breast augmentation with autologous fat grafting: a case report.
自体脂肪移植隆乳术后感染嗜沫脂环菌:1 例报告。
BMC Infect Dis. 2023 Feb 28;23(1):124. doi: 10.1186/s12879-022-07812-6.
4
Intratumoral CD8 T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.具有组织驻留记忆表型的肿瘤内CD8 T细胞介导乳腺癌的局部免疫和免疫检查点反应。
Cancer Cell. 2023 Mar 13;41(3):585-601.e8. doi: 10.1016/j.ccell.2023.01.004. Epub 2023 Feb 23.
5
The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes.免疫大逃脱:理解乳腺癌亚型中的不同免疫反应。
Cancer Discov. 2023 Jan 9;13(1):23-40. doi: 10.1158/2159-8290.CD-22-0475.
6
Breast Cancer Statistics, 2022.2022 年乳腺癌统计数据。
CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3.
7
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy.接受(新)辅助化疗的绝经后雌激素受体阳性乳腺癌患者肠道微生物群的变化
NPJ Breast Cancer. 2022 Jul 29;8(1):89. doi: 10.1038/s41523-022-00455-5.
8
Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions.乳腺癌与良性乳腺病变患者的肠道菌群分析。
Pol J Microbiol. 2022 May 31;71(2):217-226. doi: 10.33073/pjm-2022-019.
9
Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M.使用 2bRAD-M 对低生物量或降解微生物组进行种分辨测序。
Genome Biol. 2022 Jan 26;23(1):36. doi: 10.1186/s13059-021-02576-9.
10
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.